Mammalian expression systems lead the market, while prokaryotic systems grow fastest as biotech R&D investment surges worldwide.Austin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Protein Expression Market ...
Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, translation, and safety. This provides a robust foundation for stable and ...
Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ...
Loopworm recently announced a Series A funding round to commercialize its proprietary recombinant protein platform, the ...
India-based alternative feed startup Loopworm has opened a Series A funding round in support of its goal of scaling ...
To evaluate Tau PFFs' neuroinflammatory and oxidative effects, cytokine expression and antioxidant responses were measured in ...
Reagents are expected to dominate with 27.2% market share in 2025, thanks to their essential role in protein expression ...
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability.The platform has achieved ...
In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.
About Dyadic International, Inc. d/b/a, Dyadic Applied BioSolutions Dyadic Applied BioSolutions is a global biotechnology company that uses its proprietary microbial platforms to produce recombinant .
Aspiring participants of the GATE 2026 Biotechnology (BT) exam must go through the GATE Biotechnology Syllabus. The detailed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback